ICANN To Address Future of Digital Identity and Fragmentation Threats at Web Summit

The trusted steward of the Internet's Domain Name System will host sessions on the once-in-a-decade opportunity for new top-level domains and the urgent need to defend the Internet's global,multistakeholder model. TheInternet Corporation for Assigned Names and Numbers(ICANN), the nonprofit organization that coordinates the Internet's Domain Name System (DNS), will lead critical discussions on the future […]

The Metals Company Announces Third Quarter 2025 Corporate Update Conference Call for Thursday, November 13, 2025

(NASDAQ:TMC), NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) — TMC the metals company Inc. (Nasdaq: TMC) (“TMC” or the “Company”), a leading developer of the world's largest estimated undeveloped resource of critical metals essential to energy, defense, manufacturing and infrastructure, today announced that it will host a conference call on Thursday, November 13, 2025, to

NAPC Defense Launches Grant Initiative to Equip School Resource Officers Nationwide with CornerShot Tactical Systems

(PinkSheets:BLIS),(Pinksheets:BLIS), CLEARWATER, Fla., Nov. 06, 2025 (GLOBE NEWSWIRE) — NAPC Defense, Inc. (OTCID: BLIS) (“NAPC” or “the Company”), a premier U.S.-licensed armament sales and production company, is proud to announce a new campaign aimed at protecting children in schools across the United States by placing the groundbreaking CornerShot tactical system in the hands of Resource

IMUNON to Hold Third Quarter 2025 Financial Results and Business Update Conference Call on Thursday, November 13, 2025

(NASDAQ:IMNN), LAWRENCEVILLE, N.J., Nov. 06, 2025 (GLOBE NEWSWIRE) — IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announced that the Company will host a conference call at 11:00 a.m. ET on Thursday, November 13, 2025 to discuss financial results for the third quarter ended September 30, 2025,

Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Thursday, November 13, 2025

(NASDAQ:CLRB),(NASDAQ:CLRBW),(NASDAQ:CLRBZ), FLORHAM PARK, N.J., Nov. 06, 2025 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced that the company will report financial results for the third quarter ended September 30, 2025, and provide a corporate update

The Metals Company Announces Third Quarter 2025 Corporate Update Conference Call for Thursday, November 13, 2025

The Metals Company Announces Third Quarter 2025 Corporate Update Conference Call for Thursday, November 13, 2025 GlobeNewswire November 06, 2025 NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) — TMC the metals company Inc. (Nasdaq: TMC) (“TMC” or the “Company”), a leading developer of the world's largest estimated undeveloped resource of critical metals essential to energy,

NAPC Defense Launches Grant Initiative to Equip School Resource Officers Nationwide with CornerShot Tactical Systems

NAPC Defense Launches Grant Initiative to Equip School Resource Officers Nationwide with CornerShot Tactical Systems GlobeNewswire November 06, 2025 CLEARWATER, Fla., Nov. 06, 2025 (GLOBE NEWSWIRE) — NAPC Defense, Inc. (OTCID: BLIS) (“NAPC” or “the Company”), a premier U.S.-licensed armament sales and production company, is proud to announce a new campaign aimed at protecting children

IMUNON to Hold Third Quarter 2025 Financial Results and Business Update Conference Call on Thursday, November 13, 2025

IMUNON to Hold Third Quarter 2025 Financial Results and Business Update Conference Call on Thursday, November 13, 2025 GlobeNewswire November 06, 2025 LAWRENCEVILLE, N.J., Nov. 06, 2025 (GLOBE NEWSWIRE) — IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announced that the Company will host a conference call

Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Thursday, November 13, 2025

Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Thursday, November 13, 2025 GlobeNewswire November 06, 2025 FLORHAM PARK, N.J., Nov. 06, 2025 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today

Section Partners Raises $189 Million

Section Partners Announces Final Close of Two Funds Section Partners, a multi-strategy investment firm that makes structured and direct investments in late-stage, venture-backed technology companies, announced today the closing of two additional funds, Section Capital V, LP and Section Ventures II, LP. Commitments to these funds and a parallel co-investment vehicle (collectively, the “Funds”) total

Scroll to Top